Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Coffee Consumption Linked to Lower Risk of Death
Clinical Breakthroughs

Coffee Consumption Linked to Lower Risk of Death

By Anna WilliamsJul 9, 2018
Share
Facebook Twitter Email
Marilyn-Cornelis-coffee-2501
Marilyn Cornelis, PhD, assistant professor of Preventive Medicine in the Division of Nutrition, who studies the genetics of coffee consumption, was a co-author of the study.

Drinking coffee is associated with a lower risk of death, according to a new study published in JAMA Internal Medicine — including heavy coffee consumption, across various coffee types and among people with genetic differences that affect caffeine metabolism.

“Our study provides further evidence that drinking coffee, regular or decaf, can be part of a healthy diet and offers reassurance to coffee drinkers,” said Marilyn Cornelis, PhD, assistant professor of Preventive Medicine in the Division of Nutrition and a co-author of the study.

In the past, research has generally found a link between drinking coffee and a decreased risk of major diseases, including cardiovascular disease and diabetes, as well as overall mortality.

However, concerns remained about the health effects of heavy coffee drinking, particularly in people with common genetic variants that affect caffeine metabolism.

For example, previous research led by Cornelis and others has suggested that variants in CYP1A2 — the gene responsible for most caffeine metabolism — may alter the association of coffee drinking with cardiovascular-related outcomes, with a higher risk for coffee drinkers who metabolize caffeine more slowly.

In the current study, the team of investigators analyzed data from a cohort of a half million people living in the United Kingdom, ranging in age from 38 to 73. The study included data on coffee consumption, as well as genetic variants related to caffeine metabolism.

The investigators found that over 10 years of follow-up, coffee drinking was associated with a significantly lower risk of death, including among people who drank eight or more cups per day.

The benefit was also found in both slow and fast metabolizers of caffeine, as well as across various types of coffee, including ground, instant and decaffeinated coffee. The findings suggest that the caffeine in coffee is not responsible for the association between coffee drinking and a lower mortality rate, although the actual mechanism still remains unclear.

The study adjusted for demographic, health and behavioral factors, including age, sex, smoking status and BMI, among others.

Although the results are observational, the authors note that the findings provide further support that drinking coffee can be a part of a healthy diet.

Read more:

  • The Coffee Cannabis Connection
  • Studying the Epidemiology of Coffee
  • Coffee Associated With Colon Cancer Survival

The study, led by investigators at the National Cancer Institute of the National Institutes of Health (NIH), was conducted using the UK Biobank resource (applications 18623 and 21394). The UK Biobank was established by the Wellcome Trust, the Medical Research Council, the UK Department of Health, and the Scottish Government. The UK Biobank has also received funding from the Welsh Assembly Government, the British Heart Foundation, and Diabetes United Kingdom. This work used the computational resources of the NIH’s High-Performance Computing Biowulf cluster and was supported by the Intramural Research Program of the NIH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH; and the Department of Health and Human Services.

Health and Lifestyle Preventive Medicine Research
Share. Facebook Twitter Email

Related Posts

Predicting Risk of Blood Clots in Brain Tumors

Mar 16, 2023

Understanding How Exercise Induces Systemic Metabolic Benefits

Mar 15, 2023

Lieber Receives VA Rehabilitation Research and Development Award 

Mar 13, 2023

Comments are closed.

Latest News

Celebrating Feinberg’s 2023 Match Day

Mar 17, 2023

Predicting Risk of Blood Clots in Brain Tumors

Mar 16, 2023

Understanding How Exercise Induces Systemic Metabolic Benefits

Mar 15, 2023

Future Directions in Continuing Medical Education

Mar 14, 2023

Lieber Receives VA Rehabilitation Research and Development Award 

Mar 13, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
_5NM1245
230204_SERIO_MANDELL_Feinberg_Formal_0928
_5NM1715
_5NM0526
_5NM1026 (1)
_5NM1906
_5NM2173
230204_SERIO_MANDELL_Feinberg_Formal_0896
230204_SERIO_MANDELL_Feinberg_Formal_1113
230204_SERIO_MANDELL_Feinberg_Formal_1868
230204_SERIO_MANDELL_Feinberg_Formal_1237
230204_SERIO_MANDELL_Feinberg_Formal_1172

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.